M Pharma Peru Sac: D Amp

You can adjust the rating or specific details to better match your actual experience.

Peru has one of the strictest pharmaceutical regulatory bodies in Latin America. For to operate legally, they must possess:

This comprehensive vision reinforces the company's philosophy that (Chemistry unites us), integrating all stakeholders around a common goal: the health of Peruvians.

Specialized dermatological cream targeting skin hyperpigmentation. Quality Standards and Institutional Compliance d amp m pharma peru sac

is a prominent pharmaceutical wholesale and marketing company based in Lima, Peru, that specializes in delivering high-quality dermatological, respiratory, and ophthalmological solutions. Founded as part of an international expansion strategy by its Chilean parent organization, D&M Pharma Group , the Peruvian subsidiary has solidified its position over nearly two decades as an essential link in Latin America’s healthcare supply chain. Operating out of its corporate headquarters in San Isidro, Lima, the enterprise handles the commercialization, regulatory oversight, and pharmacovigilance of complex specialized therapies.

According to EMIS (Emerging Markets Information Service), the company employs around 32 people (data as of 2024), classifying it as a small to medium-sized enterprise with a focused yet highly specialized structure.

D & M Pharma Peru S.A.C. owns a valuable portfolio of registered brands that provide legal protection to its products in the Peruvian market. Among the most notable trademarks are: You can adjust the rating or specific details

Understanding the operations, compliance standards, and market influence of D amp M Pharma Peru SAC is essential for stakeholders ranging from hospital procurement managers to international drug manufacturers looking to enter the Andean region. This article provides an exhaustive analysis of the company’s structure, regulatory standing, product portfolio, and strategic importance in Peru.

: Micopirox (ciclopirox) nail lacquer formulations alongside specialized creams like Fusimed (fusidic acid) for localized topical infections.

D & M Pharma operates within a growing Peruvian pharmaceutical market, which was valued at approximately $1.35 billion in 2025. The company’s operations are subject to the technical regulations of DIGEMID , the Peruvian national authority for medicines and medical devices. D & M Pharma Peru S.A.C. Company Profile - EMIS Operating out of its corporate headquarters in San

The company maintains robust drug safety protocols to monitor and report adverse events to the (the Peruvian regulatory authority). Recent Leadership & Recognition

D & M Pharma Peru Sac offers a robust portfolio of pharmaceutical products. Whether sourcing essential medicines or specialized supplies, they have proven to be a reliable link in the supply chain. The quality of the products received has always met the necessary regulatory standards, providing peace of mind regarding patient safety and care.

D&M Pharma Peru SAC offers a wide range of pharmaceutical products and services, catering to various therapeutic areas, including:

The company’s portfolio is defined by its collaboration with various specialized divisions, providing medical professionals and patients with targeted treatments: Respiratory & Aerosol Therapy: